Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |